Skip to content
10-K

Annual Report

INVIVO THERAPEUTICS HOLDINGS CORP.

0001558370-23-002588

← back to feed
Filed
Mar 1, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2022 · Feb 24, 2023 2.86M sh
Shares Diluted FY 2022 · Dec 31, 2022 1.54M sh
Shares Diluted restated FY 2022 · Dec 31, 2021 1.32M sh
Capex FY 2022 · Dec 31, 2022 $160K
Capex FY 2022 · Dec 31, 2021 $77K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$10.48M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$8.85M
Cash And Equivalents FY 2022 · Dec 31, 2022 $16.35M
Cash And Equivalents FY 2022 · Dec 31, 2021 $19.03M
Stockholders Equity FY 2022 · Dec 31, 2022 $15.75M
Stockholders Equity FY 2022 · Dec 31, 2021 $18.12M
Stockholders Equity FY 2022 · Dec 31, 2020 $19.19M
Current Liabilities FY 2022 · Dec 31, 2022 $2.47M
Current Liabilities FY 2022 · Dec 31, 2021 $2.61M
Total Liabilities FY 2022 · Dec 31, 2022 $3.08M
Total Liabilities FY 2022 · Dec 31, 2021 $3.66M
Current Assets FY 2022 · Dec 31, 2022 $17.6M
Current Assets FY 2022 · Dec 31, 2021 $19.14M
Total Assets FY 2022 · Dec 31, 2022 $18.82M
Total Assets FY 2022 · Dec 31, 2021 $21.77M
Eps Diluted FY 2022 · Dec 31, 2022 −$6.83
Eps Diluted restated FY 2022 · Dec 31, 2021 −$7.48
Eps Basic FY 2022 · Dec 31, 2022 −$6.83
Eps Basic restated FY 2022 · Dec 31, 2021 −$7.48
Sga Expense FY 2022 · Dec 31, 2022 $5.42M
Sga Expense FY 2022 · Dec 31, 2021 $5.52M
Rd Expense FY 2022 · Dec 31, 2022 $5.23M
Rd Expense FY 2022 · Dec 31, 2021 $4.38M
Net Income FY 2022 · Dec 31, 2022 −$10.49M
Net Income FY 2022 · Dec 31, 2021 −$9.9M
Operating Income FY 2022 · Dec 31, 2022 −$10.65M
Operating Income FY 2022 · Dec 31, 2021 −$9.9M
Stock Issued FY 2022 · Oct 9, 2022 154K sh